CLINICAL_TRIALS ClinicalTrials.gov record update

ASP II (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute Ischemic Stroke

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00300196
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:00.929033+00:00
Published At: 2010-01-12T00:00:00+00:00
Record Updated At: 2010-01-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Stroke", "Cerebral Ischemia", "Brain Infarction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2010-01-12"
protocolSection.identificationModule.nctId: "NCT00300196"
protocolSection.identificationModule.officialTitle: "ASP II (Ancrod Stroke Program) Study of Acute Viprinex\u2122 for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex\u2122) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute Ischemic Stroke"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.